3.5(top 10%)
impact factor
2.4K(top 10%)
papers
69.3K(top 5%)
citations
100(top 5%)
h-index
3.9(top 10%)
impact factor
3.1K
all documents
73.8K
doc citations
147(top 5%)
g-index

Top Articles

#TitleJournalYearCitations
1Pain catastrophizing: a critical reviewExpert Review of Neurotherapeutics20091,022
2Transition from acute to chronic postsurgical pain: risk factors and protective factorsExpert Review of Neurotherapeutics2009607
3Cholinergic system during the progression of Alzheimer’s disease: therapeutic implicationsExpert Review of Neurotherapeutics2008493
4Internet-based psychological treatments for depressionExpert Review of Neurotherapeutics2012438
5The intolerance of uncertainty construct in the context of anxiety disorders: theoretical and practical perspectivesExpert Review of Neurotherapeutics2012388
6Bupropion: pharmacology and therapeutic applicationsExpert Review of Neurotherapeutics2006312
7Role of central dopamine in pain and analgesiaExpert Review of Neurotherapeutics2008312
8Sacroiliac joint pain: a comprehensive review of epidemiology, diagnosis and treatmentExpert Review of Neurotherapeutics2013291
9Drug interactions involving the new second- and third-generation antiepileptic drugsExpert Review of Neurotherapeutics2010288
10Gait training strategies to optimize walking ability in people with stroke: a synthesis of the evidenceExpert Review of Neurotherapeutics2007287
11Cyberchondria: towards a better understanding of excessive health-related Internet useExpert Review of Neurotherapeutics2013273
12Protective roles of intestinal microbiota derived short chain fatty acids in Alzheimer’s disease-type beta-amyloid neuropathological mechanismsExpert Review of Neurotherapeutics2018247
13The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorderExpert Review of Neurotherapeutics2010245
14Distinguishing Alzheimer’s disease from other major forms of dementiaExpert Review of Neurotherapeutics2011241
15Diet and Alzheimer’s disease risk factors or prevention: the current evidenceExpert Review of Neurotherapeutics2011231
16Functional neuroimaging studies of post-traumatic stress disorderExpert Review of Neurotherapeutics2011231
17The interplay between gait, falls and cognition: can cognitive therapy reduce fall risk?Expert Review of Neurotherapeutics2011230
18Environmental factors in multiple sclerosisExpert Review of Neurotherapeutics2013229
19Abnormal endogenous pain modulation is a shared characteristic of many chronic pain conditionsExpert Review of Neurotherapeutics2012228
20The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrenceExpert Review of Neurotherapeutics2015221
21Clinical implications of a staging model for bipolar disordersExpert Review of Neurotherapeutics2009214
22Loss of motor function in preclinical Alzheimer’s diseaseExpert Review of Neurotherapeutics2011200
23The use of ketamine in complex regional pain syndrome: possible mechanismsExpert Review of Neurotherapeutics2011198
24Effect of second-generation antipsychotics on cognition: current issues and future challengesExpert Review of Neurotherapeutics2010188
25Intracerebral hemorrhage: an update on diagnosis and treatmentExpert Review of Neurotherapeutics2019186
26Duloxetine in the treatment of major psychiatric and neuropathic disordersExpert Review of Neurotherapeutics2008184
27Multiple sclerosis-associated fatigueExpert Review of Neurotherapeutics2010184
28Focused ultrasound-mediated drug delivery through the blood–brain barrierExpert Review of Neurotherapeutics2015181
29Long-acting injectable naltrexone for the treatment of alcohol dependenceExpert Review of Neurotherapeutics2007180
30Behavioral, neurocognitive and treatment overlap between attention-deficit/hyperactivity disorder and mood instabilityExpert Review of Neurotherapeutics2009180
31Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapyExpert Review of Neurotherapeutics2009178
32Neurologic bases for comorbidity of balance disorders, anxiety disorders and migraine: neurotherapeutic implicationsExpert Review of Neurotherapeutics2011177
33Family accommodation in obsessive–compulsive disorderExpert Review of Neurotherapeutics2012177
34Oxidative stress and Alzheimer’s disease: dietary polyphenols as potential therapeutic agentsExpert Review of Neurotherapeutics2010175
35Clinical assessment and treatment of attention deficit hyperactivity disorder in adultsExpert Review of Neurotherapeutics2005172
36Cognitive bias modification for anxiety: current evidence and future directionsExpert Review of Neurotherapeutics2011168
37Immune therapy in autoimmune encephalitis: a systematic reviewExpert Review of Neurotherapeutics2015168
38The safety, tolerability and efficacy of pimavanserin tartrate in the treatment of psychosis in Parkinson’s diseaseExpert Review of Neurotherapeutics2016168
39Speech treatment for Parkinson’s diseaseExpert Review of Neurotherapeutics2008163
40An update on the comorbidity of ADHD and ASD: a focus on clinical managementExpert Review of Neurotherapeutics2016163
41Maladaptive plasticity, memory for pain and phantom limb pain: review and suggestions for new therapiesExpert Review of Neurotherapeutics2008159
42Convection-enhanced delivery for the treatment of brain tumorsExpert Review of Neurotherapeutics2009157
43Natalizumab: α4-integrin antagonist selective adhesion molecule inhibitors for MSExpert Review of Neurotherapeutics2004156
44Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomasExpert Review of Neurotherapeutics2010155
45Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disordersExpert Review of Neurotherapeutics2010152
46Alpha2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic useExpert Review of Neurotherapeutics2016150
47Refractory epilepsy: mechanisms and solutionsExpert Review of Neurotherapeutics2006148
48Neonatal hypoxic ischemic encephalopathy: an update on disease pathogenesis and treatmentExpert Review of Neurotherapeutics2017148
49Current treatment options for meningiomaExpert Review of Neurotherapeutics2018147
50Brain-derived neurotrophic factor and neuroplasticity in bipolar disorderExpert Review of Neurotherapeutics2008146